Product NDC: | 13925-161 |
Proprietary Name: | Sodium Sulfacetamide and Sulfur |
Non Proprietary Name: | Sodium Sulfacetamide and Sulfur |
Active Ingredient(s): | 100; 50 mg/mL; mg/mL & nbsp; Sodium Sulfacetamide and Sulfur |
Administration Route(s): | TOPICAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 13925-161 |
Labeler Name: | Seton Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20110527 |
Package NDC: | 13925-161-12 |
Package Description: | 355 mL in 1 BOTTLE (13925-161-12) |
NDC Code | 13925-161-12 |
Proprietary Name | Sodium Sulfacetamide and Sulfur |
Package Description | 355 mL in 1 BOTTLE (13925-161-12) |
Product NDC | 13925-161 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sodium Sulfacetamide and Sulfur |
Dosage Form Name | SOLUTION |
Route Name | TOPICAL |
Start Marketing Date | 20110527 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Seton Pharmaceuticals |
Substance Name | SULFACETAMIDE; SULFUR |
Strength Number | 100; 50 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes | Sulfonamide Antibacterial [EPC],Sulfonamides [Chemical/Ingredient] |